Prescient Healthcare Group has been recognized, for the third year in a row, as one of the 50 fastest-growing privately owned pharma companies in the UK. Companies in the Alantra Pharma Fast 50 are passionate about the potential of their businesses to deliver lasting...
Prescient’s Dr. Julia Seaman shares her thoughts on monitoring COVID-19 in the American Society for Quality’s March issue of Quality Progress. More data are needed to track the full implications surrounding the coronavirus crisis. Read the full report...
Prescient’s Andrea Campi’s doctoral research has yielded a published manuscript in Connective Tissue Research: Mechanosensitive Ca2+ signaling and coordination is diminished in osteocytes of aged mice during ex vivo tibial loading This work used a novel ex vivo model...
The American Society of Gene and Cell Therapy has accepted and published a manuscript from Prescient’s Carly Jones in Molecular Therapy: AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis This...
Prescient’s Andrea Campi has been recognized with the ASBMR Young Investigator Award. The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific and medical society established to bring together clinical and experimental scientists who...
The European Society of Cardiology has accepted and published a manuscript from Prescient’s Carly Jones in Cardiovascular Research: A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism This research reveals the presence of...
